4.6 Review

Treatment strategies in ischaemic left ventricular dysfunction: a network meta-analysis

期刊

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
卷 59, 期 2, 页码 293-301

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/ejcts/ezaa319

关键词

Coronary artery bypass grafting; Percutaneous coronary intervention; Medical therapy; Revascularization; Heart failure

资金

  1. Bernard S Goldman Chair in Cardiovascular Surgery
  2. British Heart Foundation Excellence [RE/18/6/34217]
  3. les Fonds la Recherche du Quebec en sante (FRQS)
  4. Canadian Institutes for Health Research (CIHR)
  5. la Fondation de l'Institut de Cardiologie de Montreal

向作者/读者索取更多资源

A network meta-analysis comparing PCI, CABG, and MT for patients with iLVSD found that CABG was associated with the best outcomes in terms of mortality, cardiac death, MI, and RR, while MT had the lowest incidence of stroke. It is suggested that definitive RCTs comparing CABG and PCI in iLVSD are needed for more conclusive evidence.
OBJECTIVES: The optimal revascularization strategy for patients with ischaemic left ventricular systolic dysfunction (iLVSD) remains controversial. We aimed to compare percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) and medical therapy (MT) in a network meta-analysis. METHODS: All randomized controlled trials and observational studies comparing any combination of PCI, CABG and MT in patients with iLVSD were analysed in a frequentist network meta-analysis (generic inverse variance method). Primary outcome was mortality at longest available follow-up. Secondary outcomes were cardiac death, stroke, myocardial infarction (MI) and repeat revascularization (RR). RESULTS: Twenty-three studies were included (n = 23 633; 4 randomized controlled trials). Compared to CABG, PCI was associated with higher mortality [incidence rate ratio (IRR) 1.32, 95% confidence interval (CI) 1.13-1.53], cardiac death (IRR 1.65, 95% CI 1.18-2.33), MI (IRR 2.18, 95% CI 1.70-2.80) and RR (IRR 3.75, 95% CI 2.89-4.85). Compared to CABG, MT was associated with higher mortality (IRR 1.52, 95% CI 1.26-1.84), cardiac death (IRR 3.83, 95% CI 2.12-6.91), MI (IRR 3.22, 95% CI 1.52-6.79) and RR (IRR 3.37, 95% CI 1.67-6.79). Compared to MT, PCI was associated with lower cardiac death (IRR 0.43, 95% CI 0.24-0.78). CABG ranked as the best revascularization strategy for mortality, cardiac death, MI and RR; MT ranked as the strategy associated with the lowest incidence of stroke. Left ventricular ejection fraction, year of study, use of drug-eluting stents did not affect relative treatment effects. CONCLUSIONS: CABG appears to be the best therapy for iLVSD, although mainly based on observational data. Definitive randomized controlled trials comparing CABG and PCI in iLVSD are required.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据